Page last updated: 2024-10-29

ketamine and Costen's Syndrome

ketamine has been researched along with Costen's Syndrome in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castrillon, EE1
Cairns, BE1
Ernberg, M1
Wang, K1
Sessle, BJ1
Arendt-Nielsen, L1
Svensson, P1

Trials

1 trial available for ketamine and Costen's Syndrome

ArticleYear
Effect of peripheral NMDA receptor blockade with ketamine on chronic myofascial pain in temporomandibular disorder patients: a randomized, double-blinded, placebo-controlled trial.
    Journal of orofacial pain, 2008,Spring, Volume: 22, Issue:2

    Topics: Adult; Analysis of Variance; Anesthetics, Dissociative; Bite Force; Chronic Disease; Double-Blind Me

2008